Lgl Partners LLC Portfolio Adjustments in Q2 2026: Focus on ETF Sales and Purchases

Lgl Partners, Llc has recently adjusted its investment portfolio for the period ending June 30, 2026. The firm's activity this quarter involved notable changes to several holdings within its diverse range of assets.

The most significant action appears to be the reduction in shares of SABRA HEALTH CARE REIT INC (SBRA). According to disclosures, Lgl Partners sold a substantial portion of their position, resulting in an 82.5 million dollar decrease and a -79.77% change in holdings from the previous quarter. This significant sell-off is detailed in the SBRA entry.

Conversely, Lgl Partners demonstrated strong buying activity during Q2 2026. The firm significantly increased its position in ISHARES TR (HDV), acquiring an additional 923.13% worth of shares compared to the prior period's holdings. Similarly, VANGUARD INDEX FDS (VOO) saw a complete restocking as Lgl bought back all previously held shares, representing a 100.0% change from the previous quarter.

Other notable purchases include ISHARES TR (IGV), where holdings increased by approximately 67.89%, and VANGUARD SCOTTSDALE FDS (VCSH) which was completely restocked at a 100.0% change from the prior period. The firm also added shares to IWF, increasing its position by about 300.28%. Furthermore, ISHARES TR (DGRO), GMO ETF TRUST (QLTY), and ISHAES TR (EEM) all showed positive changes in their holdings during this quarter.

These adjustments reflect Lgl Partners' dynamic investment strategy focused on optimizing returns across various sectors. The firm appears to be actively managing its portfolio, divesting underperforming assets like SBRA while reinvesting heavily into specific ETFs and funds that align with its current outlook.

The complete list of changes affecting the investor's holdings can be explored through the official Lgl Partners, Llc filings. This summary highlights key transactions observed in Q2 2026 based on available data.